1,184 Shares in HCA Healthcare, Inc. $HCA Acquired by Spurstone Advisory Services LLC

Spurstone Advisory Services LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,184 shares of the company’s stock, valued at approximately $454,000. HCA Healthcare comprises about 6.9% of Spurstone Advisory Services LLC’s investment portfolio, making the stock its 2nd biggest position.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Price T Rowe Associates Inc. MD boosted its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after buying an additional 587,036 shares during the period. Nuveen LLC acquired a new position in HCA Healthcare in the first quarter valued at $569,217,000. Pacer Advisors Inc. raised its stake in shares of HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Nordea Investment Management AB grew its position in HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after acquiring an additional 59,163 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Zacks Research upgraded HCA Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 29th. Sanford C. Bernstein restated a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a research note on Monday, October 27th. Truist Financial increased their price objective on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, Robert W. Baird upped their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Stock Up 0.3%

HCA opened at $472.97 on Thursday. The company’s 50-day moving average price is $425.01 and its 200 day moving average price is $389.68. The firm has a market cap of $107.93 billion, a price-to-earnings ratio of 18.28, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $478.19.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the firm earned $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.